Skip to main content

Lonapegsomatropin use while Breastfeeding

Medically reviewed by Drugs.com. Last updated on Nov 22, 2023.

Drugs containing Lonapegsomatropin: Skytrofa

Lonapegsomatropin Levels and Effects while Breastfeeding

Summary of Use during Lactation

Lonapegsomatropin is a long-acting prodrug of somatropin, which has been used safely in nursing mothers. Polyethylene glycol is not excreted into breastmilk.[3] No special precautions are required.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date. However, somatropin has been reported to increase milk production.

Alternate Drugs to Consider

Somatropin

Substance Identification

Substance Name

Lonapegsomatropin

CAS Registry Number

1934255-39-6

Drug Class

Breast Feeding

Lactation

Milk, Human

Human Growth Hormone

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.